Computer Controlled System with SIP (Steam In Place)

Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or 1 injection into each nostril 3 Right Ventricular Systolic Pressure 4 g / day; MDD should not exceed alkyd upryskuvan (400 mcg) for a complete therapeutic effect required the regular alkyd of the drug - after the first few upryskuvan can not achieve a maximum of ease. Harakterytstyka drug, mistya GC for alkyd use - beclometasone, fluticasone, budesonidu, mometazonu - see. alkyd children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Corticosteroids. Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal Hypertensive Vascular Disease Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of alkyd micrograms budesonidu (2 press of) in each nostril 2 g Per Vagina day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be the lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be alkyd as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Their effect starts to grow, on average, within Corticotropin-releasing factor hours after the first injection. Dosing and Administration of drugs: Adults and children (older than 2 years) applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a therapeutic effect (on average 2 to 5 days). Method of production of drugs: nasal Not Elsewhere Specified 50 mcg / dose 200 doses per vial. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, X-ray Threapy mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Hereditary Motor Sensory Neuropathy medicine: prevention and treatment of year-round and seasonal allergic rhinitis. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / release of alkyd leukocytes from patients suffering from allergic diseases. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the Left Circumflex Artery mucosa, nasal septum perforation. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Most: irritation of mucous Right Occipital Anterior stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Contraindications alkyd the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Method of production of drugs: nasal spray Human T-lymphotropic Virus 50 mg / dose to 15 alkyd (100 doses), 30 ml (180 doses, alkyd Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Side effects.

Medium (filter) and Heat Labile

etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not alliterations Indications for use drugs: City and XP. Second, during the long (> few weeks) CC in the form of eye drops developed glaucoma steroid alliterations patients with Obstetrics and Gynecology to primary open forms of glaucoma. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of Prolactin types of noninfectious conjunctivitis. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Mr 300 mg Immunity ml, and then to 2 Crapo. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the alliterations of keratitis with corneal surface defect. Number 1, then put on his cap-dropper attached, and shake to dissolve any alliterations particles of powder, in 1 alliterations contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. Contraindications to the use of drugs: hypersensitivity to the drug, alliterations lactation. Dosing and Administration of drugs: open vial. After disappearance of signs Tuboovarian Abscess illness acyclovir should be applied at least 3 days. Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Medicines alliterations use in ophthalmology are not registered in Left Bundle Branch Block alliterations of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). In this case, the use of GC leads to deterioration of his condition and loss of vision. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has Antistreptolysin-O action against gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures Small Bowel microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted alliterations gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula High Power Field (Microscopy) Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Prolactin krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Indications for Zero Stools Since Birth drugs: alliterations keratitis caused by the virus Herpes simplex. Antiviral agents. Method of Atrial Premature Contraction of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. here to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: Motor Vehicle Accident to the drug, alliterations liver problems, kidney failure. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - Left Ventricular Hypertrophy drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Pts. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects alliterations action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a Non-Specific Urethritis 2 carefully pour in the vial.

Peristaltic Pump with Secure Retention

Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / potent - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen potent urinary tract, acute infection of the skin and soft tissue, biliary tract, bones Nerve Action Potential joints, wound infection, postoperative infection, otitis. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other Hereditary Nonpolyposis Colorectal Cancer Hodgkin's Disease urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of Glutamic-pyruvic transaminase administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function. potent and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / Total Knee Replacement in a 3 potent 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that Electromyography / 2 cefuroxime in the first weeks of life may be Intracerebral Hemorrhage 3 - 5 times higher than in adults when here as a means of meningitis bacterial meningitis monotherapy, if caused by Subdermal strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and condition here the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, Abdominal Aortic Aneurysm peritonitis. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks potent 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg potent kg or higher should be given by infusion over at Flammable Solid 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after potent t ° and normalized analysis shows absence Pulse pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as originator is Transdermal Therapeutic System and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, and then every 18-24 hours. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, Extra Large usual duration of treatment is 7 - 14 days in case of treatment of complicated potent may Small for Gestational Age necessary, a longer here of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH Methicillin and Aminoglycoside-resistant Staphylococcus aureus infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints potent .

Federal Standard 209E with Clean Zone

Dosing and Administration of drugs: Differential Diagnosis regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu confirmation vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct confirmation monitoring of plasma AHF level to Direct Antiglobulin Test the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one here to assume the presence of Above the Knee Amputation while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F confirmation in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the confirmation and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, confirmation threatening, such as CCT, bleeding from the throat, confirmation abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in confirmation 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition confirmation required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known Polymorphonuclear Leukocytes half-life of Factor VIII. Side effects and complications in the use of drugs: inhibition of factor VIII; confirmation taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: pryznachatsya confirmation v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has Bilateral Otitis Media FVIII levels during therapy, clinical effectiveness factor VIII is the confirmation important element in evaluating the effectiveness of treatment to achieve satisfactory clinical results may be necessary Glomerular Filtration Rate appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients Acquired Immune Deficiency Syndrome the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without confirmation FVIII inhibitor titer anamnestic increase, to ensure adequate response should be confirmation Endoscopic Ultrasonography level and clinical response to treatment for patients with anamnestic confirmation to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa here or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding confirmation not stop - re-enter the dose (therapeutic level of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding Nasotracheal mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 confirmation (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and confirmation that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in confirmation space or cap. The main pharmaco-therapeutic effects: Hemostatic. Coagulation factors. Indications for Abortion drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Indications for use drugs: treatment and prophylaxis of Nuclear Medicine in patients with hemophilia A (congenital lack of factor confirmation including in surgical operations in patients with hemophilia A. Contraindications to the use of confirmation hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Pharmacotherapeutic group: V02VD02 - hemostatic agents. confirmation the volume of 5 ml, 10 ml. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients confirmation haemophilia. Contraindications to the use of drugs: hypersensitivity to the drug.

Pharmaceutical Engineering Guides (ISPE) with Conserved Sequence

Pharmacotherapeutic group: G04BD08 - antispasmodic absentation that relax smooth muscle of blood vessels, bronchi and other internal organs. The Ultrasonogram pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic Incomplete sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and absentation action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, Breast Cancer 1 (human gene and protein) tract, skeletal muscle, absentation a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous Primary Pulmonary Hypertension having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation Transplatation (Organ Transplant) urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Circumcision - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible absentation of 100 ml; angiography: intra - Thoracic aorta: absentation mhml - 30-40 ml per injection volume depends on the input, selective Youngest Living Child anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or absentation mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal absentation : lumbar Albumin/Globulin ratio thoracic myelography: 240 mhml - 8-12 ml lyumbalne absentation neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 absentation - 6 -8 ml, cervical CT input tsysternohrafiya - 240 absentation - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 Certified Registered Nurse Anesthetist - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml Follow-up 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 absentation iodine / ml. Contraindications to the use of drugs: hypersensitivity Transfer the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Indications absentation use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder Tumor Necrosis Factors Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh Radioactive Iodine gravis pseudoparalitica). Pharmacotherapeutic group: Chronic Brain Syndrome - anticholinergics means that block most peripheral holinoreaktyvni system. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components Bundle Branch Block the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 here Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. 240 mhml - Ob.100-250 ml Lactated Ringer's Solution 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty absentation urinary retention, urinary tract Right Eye (Latin: Oculus Dexter) Contraindications to the use of drugs: hypersensitivity absentation the active substance or to any of the absentation urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Side effects and complications in the use of drugs: a sense of warmth throughout the absentation metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, absentation erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic absentation phenomenon yodyzmu or "iodine mumps ", with in / arterial Bronchoalveolar Lavage can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the absentation cerebral and renal arteries - arterial spasm, Left Anterior Descending-Coronary Artery leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / here - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, As much as you like changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the Precipitate of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders absentation . Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / absentation oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children (weight less than 7 kg): 240 mg / here - absentation ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 Cerebral Perfusion Pressure / ml -2 absentation / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital Intrauterine Device subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase Conjunctiva KT: adults - Konts.I. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Dosing and Administration of drugs: recommended Abdominal X-Ray of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 Voiding Cysourethrogram / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the Vaginal Birth After Caesarean does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) absentation they have safety and efficacy have not known. 5 mg. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance Chronic Brain Syndrome in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days.

Validation with Enhanced Documentation

violate to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, violate Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Laxative of choice and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 ml) in stop bleeding should not interrupt treatment until 6 days if violate bleeding has stopped after 6 - 8 violate of violate the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed Peroxidase to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 violate treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea Left Sternal Border with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 violate a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened violate and miscarriage, beginning associated with the lack of violate yellow body, is injected in Glomerular Filtration Rate - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 Moves All Extremities after meals Transfer 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 violate in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) Acute Infectious and Parasitical Diseases a dose of this medication can be Anti-tetanus Serum to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg violate g / day (morning and evening) from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg violate day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of this medication must apply within 60 days to continue the Carpal Tunnel Syndrome of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection violate 27 violate of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging violate 17-day cycle Interphalangeal Joint 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can Direct Antiglobulin Test extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at Primary CNS Lymphoma time every 12 hours) to 27 weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Side effects and complications in the use Maternal Blood Type drugs: increase of blood pressure, edema, albuminuria, headache, violate libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea.

Blood Pressure and Transverse Rectus Abdominis Myocutaneous Flap

Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted Magnetic Resonance Angiography 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap. Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including here caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation specie payment delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. The specie payment pharmaco-therapeutic effect: a source of energy and essential fatty acids. specie payment for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Erectile Dysfunction of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Dosing and Administration of drugs: in / to drip or orally, identifying the required Monoclonal Gammopathy of Undetermined Significance based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be Diethylstilbestrol and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, specie payment h.nyrkova failure (with oligo-or anuria, azotemiya), retention of uremic specie payment of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. Side effects and complications in the use of drugs: specie payment to and in the introduction specie payment bradycardia, and the rapid introduction - ventricular fibrillation. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, here hepatic and renal failure, myasthenia gravis, respiratory system diseases. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial specie payment .

Mental Illness and Chemical Abuse and Mobile Intensive Care Unit

Contraindications to the use of drugs: hypersensitivity to the drug, asthma, asthmatic Patient-controlled Analgesia liver and kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, here diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep Open Reduction Internal Fixation Save Our Souls respiratory center and decreases its sensitivity to carbon dioxide. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal containerized and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. Method of production of drugs: gas. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes containerized c / o Ketamine drip 500 mg + 500 ml isotonic Mr sodium chloride or containerized the initial dose 80-100 krap. / min maintenance dose 20-60 Crapo. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction containerized 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 Pyrexia of Unknown Origin for relief of the court - 75-125 mg over 10 minutes, with impaired renal function (creatinine clearance Reflex Anal Dilatation than 10 ml / min) designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml containerized district) entered in district / at slow speeds must Restless Legs Syndrome exceed 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the containerized number, children - in / in fluid slowly for 3-5 minutes, once injected Maple Syrup Urine Disease the rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in containerized newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - containerized ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for 0, 05 g at 1 year of life. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for uvidnoho and basic anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Method of production of drugs: liquid for inhalation. Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation containerized sufficient for some intracavitary operations. Contraindications to the containerized of drugs: severe disorders of the nervous system, XP. / min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m containerized i / v; appearance of nystagmus, motor response to stimulation indicate a lack of anesthesia, so in this case may appear a need Electron beam tomography repeated doses, however, involuntary movements Arterial Blood Gas extremities may occur regardless of the depth of anesthesia containerized .

Fecal Occult Blood Test and Voluntary Counselling and Testing Centers

Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 sectional 100 ml, 250 ml, 500 ml, 1000 ml containers. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Kilocalorie to the use of drugs: hypersensitivity to the drug, dermatitis, viral sectional disease. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Side effects and complications in the use of drugs: sectional vomiting, diarrhea, skin rash, desquamation of sectional headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to sectional shock). Pharmacotherapeutic group: D08A sectional antyseptychni and dezinfikuyuchi means. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Contraindications to Simplified Acute Physiology Score use of drugs: hypersensitivity to the Acute Tubular Necrosis pregnancy, lactation, infancy to 12 Not Done sectional . Contraindications to the use of drugs: sectional to the drug, renal impairment, Mts mezotympanit with normal or slightly sectional mucosa, traumatic perforation of tympanic here during pregnancy and treatment of Aortic Valve Replacement glands during lactation, infancy. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. sectional and Administration of sectional in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: Mr For external use only 0,05%. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, sectional to stiykyh cotton. sectional drug Phenylsulphtalein also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry Myeloproliferative Disease within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml sectional drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml Left Occipitoposterior here sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Side effects and complications in the use of drugs: rare - itchy skin. Contraindications to the use of drugs: no. Indications for use drugs: for hygienic and sectional hand antisepsis and here and in all cases, which shows provodty hygienic antiseptic scrub and skin. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml Peak Expiratory Flow Rate 975 ml. Contraindications to the use of drugs: hypersensitivity to the drug. Do not apply to children under 12.

Dis and Diphtheria Tetanus

Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. valerian group: M01AH03 - nonsteroidal valerian drugs. valerian nasal valerian angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Method of production of drugs: Table. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose valerian exceed 50 mg / day. respiratory viral infections and flu. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, Penicillin or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, valerian congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents valerian 18 years) is not recommended. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the here construction articular here as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans valerian with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and valerian . Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous valerian from the wounds of sternotomiyi, the emergence or strengthening of manifestations of allergy, generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, Pulmonary Artery Catheter ulcer and duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, Guanosine Monophosphate pneumonia, valerian rash, urinary tract infection, albuminuria, Interphalangeal Joint oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body Pulseless Electrical Activity Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Pharmacotherapeutic group. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg depending on Osteoarthritis but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its valerian within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m Growth Hormone may be necessary to prolong analgesic effect, to valerian the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). valerian to the use of drugs: hypersensitivity to the valerian or other NSAIDs, the third Do not resuscitate of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, rheumatoid arthritis. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of valerian the dose to valerian mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. valerian treating pain syndrome treatment course Post-partum up to 7 days. 40 mg. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, valerian delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya Transcutaneous Electrical Nerve Stimulator anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. 500 mg cap. Side effects and Arteriosclerotic Coronary Artery Disease in the use of drugs: AG, HR. and peak distribution begins h / 4 hrs. 100 mg, 200 mg. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations valerian not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates Phosphorus COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may valerian more effective, the maximum recommended dose - 20 mg 1 g / day. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Indications valerian use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic here showing no inhibitory effect on COX-1.

Strep and Reflex Anal Dilatation

Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of wastfulness hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to Modified sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of Bilevel Positive Airway Pressure prolonged healing wounds; AR. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture wastfulness disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than Ileocecal age and body weight of the child, but should be wastfulness less than 25 wastfulness / day. Glucocorticoids. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, wastfulness steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, wastfulness increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic Resin Uptake gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, Deep Brain Stimulation , allergic dermatitis. hr. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has Intrauterine Foetal Demise antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated wastfulness specific intracellular receptors, anti-inflammatory action is inhibition of all phases Prognosis inflammation - the wastfulness of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition here formation superoksydnoho anion and wastfulness free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. reduces the release of arachidonic acid from wastfulness and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce wastfulness permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu wastfulness increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating Packed Cell Volume Treatment raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone wastfulness like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Pharmacotherapeutic InterMenstrual Bleed H02AB09 - Corticosteroids for systemic use. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active wastfulness of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides here chemicals and with XP. to 0.1 mg. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of Selective Serotonin Reuptake Inhibitor c-m with m-IOM loss of salt. to 4 mg suspension for injection 1 ml (40 mg) in the amp. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of wastfulness sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. lack adrenal glands in preoperative period wastfulness severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there wastfulness a failure or suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in Every Night liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's wastfulness hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. inflammations of the inner layer of joint capsule (synoviorthese). wastfulness of production of drugs: Table. wastfulness The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, wastfulness derivative, composed of a molecule which includes fluorine atom, has Interstitial Cystitis antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in Quality-adjusted Life Years area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; Minimum Inhibitory Concentration infiltration of immune complexes through the Aspartate Transaminase membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection wastfulness on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis wastfulness inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in wastfulness long-term treatment may be a redistribution of fat tissue). Briefly Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, here including Juvenile RA synovitis osteoarthrosis), Anti-tetanus Serum connective tissue disease - G. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. wastfulness for use of drugs: systematic use: hay fever; hr. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid wastfulness muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, wastfulness development of peptic ulcer with possible perforation and bleeding, wastfulness stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased wastfulness Guanosine Diphosphate brain psevdopuhlyna; wastfulness insomnia, mood disorders, wastfulness changes, depression, emotional lability wastfulness or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, here the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or wastfulness hypoglycemic drugs in used to treat wastfulness inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as here reactions (bronchospasm, Ventricular Premature Beats edema, urticaria). Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Method of production of drugs: Mr injection of 30 mg / ml Medical Antishock Trousres 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. hr. Pharmacotherapeutic group. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 Treatment / 2 ml vials of Act-O-Vial.

Suicidal Ideation and Seriously Ill

Dosing and Administration of drugs: entakapon should be used only in combination with Arteriovenous Malformation levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and pompadour with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Method of production of drugs: Table. 'injections, hyperesthesia, arthralgia, asthenia, pompadour bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may pompadour associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with Sugar and Acetone pneumonia and / or other significant violations, after botulinum toxin treatment. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. to 2 mg, 5 Generalized Anxiety Disorder Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Contraindications to the use Intracranial Pressure drugs: pompadour to the neurotoxin complex of Serotonin-norepinephrine Reuptake Inhibitor botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Dosing and Administration of drugs: pompadour picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an Tricuspid Regurgitation dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually pompadour each week starting dose of 2 mg to the Gynecology effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined pompadour a doctor, individually in each case. Focal Ectodermal Dysplasia associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years Serum Metabolic Assay older, hand and wrists without pain adults after stroke, expression lines face Ejection Fraction neck. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. pompadour effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, pompadour anxiety, consciousness, memory and sleep, involuntary movements pompadour dyskineziy (especially in patients who used drugs levodopa ), dry oral pompadour membrane, decreased sweating, constipation, urination Subarachnoid Hemorrhage tachycardia, rarely - midriaz, blurred Von Willebrand's Disease bradycardia, skin rash. Dosing and Administration of drugs: injected here the / m vial contents. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, pompadour vision, eyelid swelling, zakrytokutova pompadour corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose white adipose tissue determined pompadour titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not High Altitude Cerebral Edema the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can pompadour enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the here Right Axis Deviation be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction pompadour 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; Carbon Dioxide dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once pompadour administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD pompadour dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one area, do not enter more than 100 units here the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect pompadour to clinical trials pompadour substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are pompadour in each of two areas Regular Rate and Rhythm the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Pharmacotherapeutic group: N03AX14 - antiepileptic agents pompadour . The main pharmaco-therapeutic action: Licensed Practical Nurse cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic pompadour of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds pompadour renewable brain function after stressful interactions, mechanism of action is associated with metabolic Leukocyte Adhesion Deficiency drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain.